NYSE$RMD

ResMed Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

ResMed's first quarter results for fiscal year 2022 showed strong performance with double-digit growth in both top-line and bottom-line metrics.

ResMed Inc. reported a 20% increase in revenue to $904.0 million and a 21% increase in operating profit for the first quarter of fiscal year 2022. The company's performance was driven by high demand for sleep and respiratory care products and steady growth in its software-as-a-service business, despite ongoing supply chain challenges.

  • Revenue increased by 20% to $904.0 million, or 19% on a constant currency basis.
  • Diluted earnings per share were $1.39, while non-GAAP diluted earnings per share reached $1.51.
  • Income from operations increased by 21%, with non-GAAP operating profit up by 18%.
  • Software as a Service revenue increased by 6%, driven by continued growth in resupply service offerings and stabilizing patient flow in out-of-hospital care settings.

Headline financials

Total Revenue

$904M

Previous: $752M+20.2%
EPS (adj)

$1.51

Previous: $1.27+18.9%
Capital Expenditures

-$27.3M

Previous: -$13.5M-102.5%
Free Cash Flow

$176M

Previous: $165M+6.9%
Net Income

$204M

Previous: $178M+14.2%
Operating Income

$262M

Previous: $217M+20.8%
Gross Profit

$506M

Previous: $439M+15.4%
Cash & Equivalents

$276M

Previous: $421M-34.5%
Total Assets

$4.73B

Previous: $4.62B+2.3%
Stock-Based Comp

$17.3M

Previous: $16.1M+7.7%

Revenue & EPS history

ResMed · Revenue · Quarterly

$904M

Q1 2022+20.2%vs Q1 2021
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

ResMed · $904M total across 3 segments · Q1 2022

  • Total Devices
    $494M
  • Total Masks and other
    $312M
  • Residential Care Software
    $97.5M

Forward guidance

No specific forward guidance was provided in the earnings report.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.1%

Avg return

Earnings day

+0.7%

Avg return

5 days after

+1.2%

Avg return

30 days after

49%

33 / 67 earnings

Positive

+18.7%

Q3 2024

Best reaction

-19.3%

Q2 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026-2.9%-2.0%-10.8%
Q2 2026-1.5%+2.1%-0.5%
Q1 2026-1.5%-2.8%+1.4%
Q3 2025+10.1%+10.9%+13.2%
Q2 2025-8.3%-5.8%-9.4%
Q1 2025+7.9%+2.9%+2.7%
Q4 2024+4.9%+2.6%+14.9%
Q3 2024+18.7%+16.4%+16.0%
Q2 2024+6.5%+9.3%+5.2%
Q1 2024-4.2%+0.5%+9.5%
Q4 2023-19.3%-19.3%-28.3%
Q3 2023+7.6%+5.4%-3.8%
Q2 2023-2.8%-1.2%-8.5%
Q1 2023-6.5%-5.6%-1.7%
Q4 2022-1.5%-3.1%-3.1%
Q3 2022-6.9%-8.5%-3.0%
Q2 2022-6.5%+0.5%+6.2%
Q1 2022-1.9%-2.1%-6.3%
Q4 2021+0.5%+0.7%+8.3%
Q3 2021-10.6%-8.6%-2.0%
Q2 2021-5.8%-3.5%-9.9%
Q1 2021+6.2%+12.1%+16.0%
Q4 2020-13.4%-13.6%-14.4%
Q3 2020+1.8%+2.0%+2.9%
Q2 2020-4.1%+0.6%-4.1%
Q1 2020+13.8%+15.7%+14.6%
Q4 2019+1.1%+3.8%+5.4%
Q3 2019+7.9%+7.6%+9.3%
Q2 2019-19.3%-21.5%-13.6%
Q1 2019+6.2%+7.3%+5.7%
Q4 2018-2.1%+0.7%+4.1%
Q3 2018-2.1%-1.4%+6.9%
Q2 2018+13.2%+15.9%+5.1%
Q1 2018+7.7%+7.4%+8.6%
Q4 2017-6.0%-2.6%+0.6%
Q3 2017-5.2%-2.7%-2.3%
Q2 2017+9.5%+7.1%+13.7%
Q1 2017-5.0%-5.3%-8.7%
Q4 2016+5.8%+6.5%+6.0%
Q3 2016-7.4%
Q2 2016+7.1%
Q1 2016+0.1%
Q4 2015+3.6%
Q3 2015-10.3%
Q2 2015+8.6%
Q1 2015+9.5%
Q4 2014-4.1%
Q3 2014-0.4%
Q2 2014-5.7%
Q1 2014-13.2%
Q4 2013+0.5%
Q3 2013+0.9%
Q2 2013+7.0%
Q1 2013-4.7%
Q4 2012+12.8%
Q3 2012+7.6%
Q2 2012+9.7%
Q1 2012-12.0%
Q4 2009-5.4%
Q4 2011-5.4%
Q3 2011-0.9%
Q3 2010-0.9%
Q2 2010+2.2%
Q2 2011+2.2%
Q1 2010+3.6%
Q1 2011+3.6%
Q4 2010+3.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro